Read + Share
Grieve C, Joseph A, Drullinsky P, Zelenetz AD, et al. Phase I study of bendamustine, rituximab, ibrutinib, and venetoclax in relapsed,
refractory mantle cell lymphoma. Leuk Lymphoma 2024;65:235-241.
PMID: 38264906
|
 |
|
Grieve C, Joseph A, Drullinsky P, Zelenetz AD, et al. Phase I study of bendamustine, rituximab, ibrutinib, and venetoclax in relapsed,
refractory mantle cell lymphoma. Leuk Lymphoma 2024;65:235-241.
PMID: 38264906
|
|
|
|